Protocol number: APD334-202 A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease. ARENA APD334-202. Lilly, Sub-Investigator - Faz 3